You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

thrombopoietin receptor agonists

Showing 1 - 25 of 8,066
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immune Thrombocytopenia Purpura Trial in Cairo (Dexamethasone, Prednisolone and Azathioprine, Rituximab)

Recruiting
  • Immune Thrombocytopenia Purpura
  • Cairo, Egypt
    EL-Kasr elineiy
May 6, 2023

Aplastic Anemia, CSA, Drug Therapy Trial in Beijing (CsA+ATG+Herombopag, CsA+Herombopag)

Recruiting
  • Aplastic Anemia
  • +2 more
  • Beijing, China
    Peking union medical college hospital
Aug 20, 2023

Thrombopoietin Agonists in Idiopathic Thrombocytopenic Purpura

Not yet recruiting
  • ITP - Immune Thrombocytopenia
  • eltrombopag and romiplastim
  • (no location specified)
Nov 16, 2023

Oral Thrombopoietin Receptor Agonist in Pediatric Chronic ITP

Not yet recruiting
  • Thrombopoietin Receptor Agonist
    • (no location specified)
    May 4, 2023

    Persistent or Chronic ITP Trial in Creteil (Tpo-RA discontinuation)

    Unknown status
    • Persistent or Chronic ITP
    • Tpo-RA discontinuation
    • Creteil, France
      Henri-Mondor Hospital
    Feb 17, 2020

    Glaucoma, Suspect, Aberration, Corneal Wavefront Trial in Banha (Low dosage selective alpha-2 receptor agonists topical eyedrop,

    Recruiting
    • Glaucoma, Suspect
    • Aberration, Corneal Wavefront
    • Low dosage selective alpha-2 receptor agonists topical eyedrop
    • High dosage selective alpha-2 receptor agonists topical eyedrop
    • Banhā, QA, Egypt
      Ahmed Abdelshafy
    Jan 2, 2023

    Glucagon-like Peptide-1 Receptor Agonists According to Type 2

    Recruiting
    • Diabetes Mellitus, Type 2
    • GLP-1 receptor agonist
    • Bari, Italy
      Azienda Ospedaliero-Universitaria Policlinico Bari
    Nov 4, 2023

    Type 2 Diabetes Trial in Lancaster (Exenatide Injection, Saline injection)

    Terminated
    • Type 2 Diabetes
    • Exenatide Injection
    • Saline injection
    • Lancaster, Pennsylvania
      Amish Research Clinic
    Mar 6, 2023

    Preoperative Prandial State of Patients Taking Glucagon-Like

    Recruiting
    • Pulmonary Aspiration
    • Gastric ultrasound
    • Houston, Texas
      The University of Texas Health Science Center at Houston
    Jun 6, 2023

    Poor Graft Function Trial (Decitabine, Granulocyte Colony-Stimulating Factor, Thrombopoietin Receptor Agonist)

    Not yet recruiting
    • Poor Graft Function
    • (no location specified)
    Jun 8, 2023

    Glucagon-like Peptide 1 Receptor Agonists and Mental Health

    Not yet recruiting
    • Diabetes Mellitus
    • +2 more
    • GLP-1 receptor agonist
    • (no location specified)
    Aug 4, 2022

    Diabetes Trial in Nanjing (Duragtide, Semaglutide, losenatide, tirzepatide, ebenatide, etc)

    Recruiting
    • Diabetes
    • Duragtide, Semaglutide, losenatide, tirzepatide, ebenatide, etc
    • Nanjing, China
      Nanjing First Hospital, Nanjing Medical Univesity
    Aug 6, 2023

    Morbid Obesity, Metabolic Syndrome, Diabetes Trial in Columbia (GLP-1 receptor agonist)

    Not yet recruiting
    • Morbid Obesity
    • +4 more
    • GLP-1 receptor agonist
    • Columbia, Missouri
      University of Missouri Hospital
    Nov 20, 2023

    Osteoporosis, Postmenopausal, Diabetes, Type 2 Trial in Jackson (GLP-1 receptor agonist)

    Recruiting
    • Osteoporosis, Postmenopausal
    • Diabetes Mellitus, Type 2
    • GLP-1 receptor agonist
    • Jackson, Mississippi
      University of Mississippi Medical Center
    Aug 5, 2022

    Aging, Diabetes, Type 2, PreDiabetes Trial in San Antonio (Semaglutide Injectable Product, Lifestyle Counseling)

    Recruiting
    • Aging
    • +3 more
    • Semaglutide Injectable Product
    • Lifestyle Counseling
    • San Antonio, Texas
      UT Health San Antonio
    Apr 3, 2023

    Stem Cell Transplant Complications Trial in Suzhou (Eltrombopag 25 MG Oral Tablet, Thrombopoietin)

    Not yet recruiting
    • Stem Cell Transplant Complications
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Jul 17, 2022

    Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia,

    Recruiting
    • Autoimmune Hemolytic Anemia
    • +5 more
    • cytokine essays
    • +6 more
    • Milano, Italy
      Fondazione Irccs Ca' Granda Ospedale Maggiore Policlinico
    Jul 3, 2023

    Therapeutic Drug Use for CKD Patients

    Active, not recruiting
    • Chronic Kidney Disease
    • angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, calcium channel blockers, β Receptor blocker
    • Jinan, Shandong, China
      Xiao Li，MD
    Apr 18, 2023

    Psychiatric Disorder, Benzodiazepine Withdrawal Trial in Étampes (Essences and Essential Oils)

    Recruiting
    • Psychiatric Disorder
    • Benzodiazepine Withdrawal
    • Essences and Essential Oils
    • Étampes, France
      Etablissement Public de Santé Barthélemy Durand
    Oct 15, 2022

    MDS, Thrombocytopenia Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Eltrombopag)

    Completed
    Has Results
    • Myelodysplastic Syndromes
    • Thrombocytopenia
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Mar 8, 2022

    Opioid Analgesic Adverse Reaction Trial in Taiyuan (Esketamine, Sulfentanil or/and Remifentanil)

    Recruiting
    • Opioid Analgesic Adverse Reaction
    • Esketamine, Sulfentanil or/and Remifentanil
    • Taiyuan, Shanxi, China
      Zheng Guo
    Apr 18, 2022

    Poor Graft Function Trial (decitabine, umbilical cord blood, Granulocyte-colony stimulating factor)

    Not yet recruiting
    • Poor Graft Function
    • (no location specified)
    Dec 29, 2022

    GLP-1 Receptor Agonists on Efficacy and Persistence, Adherence

    Completed
    • Type 2 Diabetes
    • Obesity
    • Valencia, Spain
      INCLIVA
    Sep 6, 2022

    A Pan-European Post-Authorisation Safety Study: Risk of

    Not yet recruiting
    • Pancreatic Cancer
    • Exenatide
    • Non-GLP-1 RA based glucose lowering drugs
    • (no location specified)
    Dec 21, 2022

    Based on Data From German Sick Funds That Looks at Costs of

    Completed
    • Diabetes Mellitus, Type 2
    • Ingelheim am Rhein, Germany
      Boehringer Ingelheim
    Jan 18, 2022